Role of conservative surgery in ovarian cancer: the European experience

被引:40
作者
Colombo, N
Parma, G
Lapresa, MT
Maggi, F
Piantanida, P
Maggioni, A
机构
[1] Univ Milan, Gynecol Oncol Unit, European Inst Oncol, I-20141 Milan, Italy
[2] Univ Novara, Dept Obstet & Gynecol, Novara, Italy
关键词
conservative surgery; epithelial ovarian cancer; fertility preservation;
D O I
10.1111/j.1525-1438.2005.00428.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although less frequently than in older women, about 15% of invasive epithelial ovarian cancer may occur in young women, for whom preservation of fertility potential is an important clinical goal. We reviewed the published evidences from the European literature on the role of conservative surgery in women with invasive epithelial ovarian cancer. Three reports were identified from the Italian and French literature; the data were analyzed together with our own experience in terms of relapse rate, relapse in the preserved ovary, survival, and fertility outcome. A total of 152 conservative surgeries were reported: 88 patients with stage IA, 2 with stage IB, 51 with stage IC, 2 with stage II, 3 with stage IIIA, and 6 with stage IIIC. Relapses occurred in 18/152 patients (11.8%) and involved the preserved ovary in 11 cases (7%). Fifty-three pregnancies were recorded with 38 uneventful term deliveries, 2 ectopic pregnancies, 6 spontaneous abortions, 4 terminations, and 2 with unknown outcome. Nine patients (5.9%) have died of disease. These findings confirm that young women with stage I invasive epithelial ovarian cancer may receive a successful treatment of their disease without sacrificing fertility.
引用
收藏
页码:206 / 211
页数:6
相关论文
共 20 条
[1]   Occult bilateral involvement in Stage I epithelial ovarian cancer [J].
Benjamin, I ;
Morgan, MA ;
Rubin, SC .
GYNECOLOGIC ONCOLOGY, 1999, 72 (03) :288-291
[2]  
BROWN C, 2003, P SGO
[3]   CONTROVERSIAL ISSUES IN THE MANAGEMENT OF EARLY EPITHELIAL OVARIAN-CANCER - CONSERVATIVE SURGERY AND ROLE OF ADJUVANT THERAPY [J].
COLOMBO, N ;
CHIARI, S ;
MAGGIONI, A ;
BOCCIOLONE, L ;
TORRI, V ;
MANGIONI, C .
GYNECOLOGIC ONCOLOGY, 1994, 55 (03) :S47-S51
[4]  
KOTTMEIER HL, 1968, UICC MONOGRAPH SERIE, V2
[5]  
Low JJH, 2000, CANCER-AM CANCER SOC, V89, P391, DOI 10.1002/1097-0142(20000715)89:2<391::AID-CNCR26>3.3.CO
[6]  
2-M
[7]   Conservative treatment in epithelial ovarian cancer:: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Societe Francaise d'Oncologie Gynecologique) [J].
Morice, P ;
Leblanc, E ;
Rey, A ;
Baron, M ;
Querleu, D ;
Blanchot, J ;
Duvillard, P ;
Lhommé, C ;
Castaigne, D ;
Classe, JM ;
Bonnier, P .
HUMAN REPRODUCTION, 2005, 20 (05) :1379-1385
[8]   IS CONSERVATIVE THERAPY EVER JUSTIFIED IN STAGE 1 (1A) CANCER OF OVARY [J].
MUNNELL, EW .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1969, 103 (05) :641-&
[9]   Conservative surgery in high-risk epithelial ovarian carcinoma [J].
Raspagliesi, F ;
Fontanelli, R ;
Paladini, D ;
diRe, EM .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1997, 185 (05) :457-460
[10]   Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy [J].
Schilder, JM ;
Thompson, AM ;
DePriest, PD ;
Ueland, FR ;
Cibull, ML ;
Kryscio, RJ ;
Modesitt, SC ;
Lu, KH ;
Geisler, JP ;
Higgins, RV ;
Magtibay, PM ;
Cohn, DE ;
Powell, MA ;
Chu, C ;
Stehman, FB ;
van Nagell, J .
GYNECOLOGIC ONCOLOGY, 2002, 87 (01) :1-7